Screening for anal cancer: Endpoints needed

The Lancet Oncology

Volumn 13, Issue 5, 2012, Pages 438-440

  Wentzensen, Nicolas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ANUS CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CARCINOGENESIS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LETTER; MALE HOMOSEXUAL; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; SECONDARY PREVENTION; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION; VIRUS CARCINOGENESIS;

ANUS NEOPLASMS; CARCINOMA IN SITU; EARLY DETECTION OF CANCER; HIV INFECTIONS; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS;

EID: 84860438758     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70101-8     Document Type: Letter

References (8)

1. Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012, published online March 23. 10.1016/S1470-2045(12)70080-3.
2. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011, 103:368-383.
3. Nyitray AG, da Silva RJ, Baggio ML, et al. The prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: the HIM study. Sex Transm Dis 2011, 38:932-940.
4. Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011, 365:1576-1585.
5. Chung SH, Franceschi S, Lambert PF Estrogen and ERalpha: culprits in cervical cancer?. Trends Endocrinol Metab 2010, 21:504-511.
6. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008, 9:425-434.
7. Castle PE, Schiffman M, Wheeler CM, Solomon D Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 2009, 113:18-25.
8. Sahasrabuddhe VV, Luhn P, Wentzensen N Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol 2011, 6:1083-1098.